Opendata, web and dolomites

NEUROON-MED SIGNED

NEUROON-MED – the future of at-home diagnosis of sleep disorders

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 NEUROON-MED project word cloud

Explore the words cloud of the NEUROON-MED project. It provides you a very rough idea of what is the project "NEUROON-MED" about.

risk    calculated    technological    disorders    90    span    intelligence    2018    economic    combined    world    brainwaves    treatment       sleep    severe    psg    inteliclinic    customers    billion    diagnosing    expectancy    stopping    eye    neuroon    artificial    algorithms    commercialisation    people    price    limited    smei    motor    markets    15    effectiveness    shorter    115    mask    med    diagnosis    remote    crashes    eog    monitors    never    distinguishing    gold    movements    suffer    solutions    lower    market    excellence    moderate    harvard    pulse    sa    stages       diagnosed    oximetry    85    specialists    screening    worldwide    cagr    epidemic    inexpensive    device    2019    advantage    vehicle    medicine    fast    registration    rate    accounts    perfectly    competitors    data    apnea    medical    million    home    variants    life    school    clinical    sevenfold    aligned    diagnostic    massive    eeg    solution    polysomnography    standard    sensors    additionally    more   

Project "NEUROON-MED" data sheet

The following table provides information about the project.

Coordinator
INTELICLINIC SP. Z.O.O. 

Organization address
address: KIJOWSKA 3
city: WARSZAWA
postcode: 03-738
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Poland [PL]
 Project website https://neuroonopen.com/
 Total cost 2˙321˙250 €
 EC max contribution 1˙624˙875 € (70%)
 Programme 1. H2020-EU.2.1.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT))
2. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
 Code Call H2020-SMEINST-2-2016-2017
 Funding Scheme SME-2
 Starting year 2017
 Duration (year-month-day) from 2017-06-01   to  2020-05-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    INTELICLINIC SP. Z.O.O. PL (WARSZAWA) coordinator 1˙624˙875.00

Map

Leaflet | Map data © OpenStreetMap contributors, CC-BY-SA, Imagery © Mapbox

 Project objective

More than 100 million people suffer from sleep apnea (SA) worldwide according to the WHO data. People with SA have a life expectancy 20 years shorter than the average life span. Additionally, they have a three- to sevenfold increased risk of motor vehicle crashes. The economic impact of sleep disorders is massive, specialists from the Harvard School of medicine calculated that costs of SA only in the US accounts for $115 billion every year. The main problem the world is facing with stopping the SA epidemic is not a treatment but diagnosis. It is estimated that 85% of people who suffer from SA have never been diagnosed. The reason for the low screening rate of SA is a limited access to polysomnography (PSG) – the gold standard for testing sleep disorders. At Inteliclinic, we have developed the NeuroOn-MED mask which is addressing the customers need for effective and inexpensive solution for home diagnosis of SA. Our advantage over competitors is built upon the technological excellence of NeuroOn-MED, which analyses the brainwaves and eye movements in the same way as PSG does. The sensors of NeuroOn-MED (EEG, EOG, pulse oximetry, and others) combined with artificial intelligence algorithms for sleep data analysis provide 90% of PSG effectiveness, allowing for distinguishing between sleep stages and various variants of SA. Comparing with the currently offered home sleep monitors which are capable only of diagnosing moderate and severe SA cases. Moreover, the price of our device will be lower than currently offered solutions. NeuroOn-MED is perfectly aligned with new trends in remote diagnosis of sleep disorders. The market of SA diagnostic devices is expected to reach a value of $7.3 billion in 2018, with a CAGR of 15.0%. The proposed SMEI-funded project will be focused on clinical studies of the NeuroOn-MED, which will lead to registration as a medical device and fast commercialisation on European and US markets in 2019-20.

 Deliverables

List of deliverables.
NeuroOn-MED product specification Documents, reports 2020-01-31 16:50:17

Take a look to the deliverables list in detail:  detailed list of NEUROON-MED deliverables.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "NEUROON-MED" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "NEUROON-MED" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.2.1.1.;H2020-EU.2.3.1.)

Assist (2015)

Telocate ASSIST – Development and marketing of an acoustic solution for localization and navigation of people in buildings using the smartphone

Read More  

Digital Iris (2018)

Bringing the human being into the digital loop

Read More  

BioAhead (2017)

BioAhead – an innovative optimization algorithm for amino acid chain analytics

Read More